Karim Chamie, MD, Associate Professor of Urology and Society of Urologic Oncology Fellowship Director at UCLA Health. In this video, he speaks about the ASCO 2022 Abstract – Final clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive CIS and papillary nonmuscle-invasive bladder cancer (NMIBC). Origins: Patients with NMIBC CIS who … Continue reading Karim Chamie, MD @UclaUrology #ASCO22 #OncoTwitter Phase 2/3 QUILT-3.032 Trial